ARID1A alteration in aggressive urothelial carcinoma and variants of urothelial carcinoma
Authors:
- 1 September 2016
- journal article
- Published by Elsevier in Human Pathology
- Vol. 55, 17-23
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapyLaboratory Investigation, 2014
- ARID1A Alterations Are Associated with FGFR3-Wild Type, Poor-Prognosis, Urothelial Bladder TumorsPLOS ONE, 2013
- Clinical Applications of Recent Molecular Advances in Urologic MalignanciesAdvances in Anatomic Pathology, 2013
- ARID1A Mutations in Cancer: Another Epigenetic Tumor Suppressor?Cancer Discovery, 2013
- Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid CarcinomaInternational Journal of Gynecological Cancer, 2012
- Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladderNature Genetics, 2011
- Mutation and Loss of Expression of ARID1A in Uterine Low-grade Endometrioid CarcinomaAmerican Journal of Surgical Pathology, 2011
- A Novel Epigenetic Phenotype Associated With the Most Aggressive Pathway of Bladder Tumor ProgressionJNCI: Journal of the National Cancer Institute, 2010
- Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implicationsLaboratory Investigation, 2009
- Urothelial tumorigenesis: a tale of divergent pathwaysNature Reviews Cancer, 2005